Cardiovascular MR Perfusion Imaging: Good Initial Alternative in Stable Chronic Angina

Cardiovascular MR Perfusion ImagingIn the initial management of patients with stable chronic angina, a non-invasive strategy with cardiovascular MR perfusion imaging seems to provide similar results to invasive strategies.

 

At one year, MACE rate (combination of all cause death, non-fatal infarction and target vessel revascularization) resulted 3.3% for MRI vs. 3.9% for fractional flow reserve (FFR) informed invasive strategy. This difference was not significant (p=0.62). Outcomes were similar, despite the lower revascularization rate in the MRI arm (36.0% vs. 44.2%; p= 0.0053).

 

Cardiovascular MR perfusion imaging could be considered the best non-invasive alternative available, since it provides information on anatomy, function and myocardial structure in one single study with no use of iodine radiation.

 

The study randomized 918 patients with chronic stable angina (functional class II or III) at intermediate to high risk of coronary artery disease justified by at least two cardiovascular risk factors and one positive exercise treadmill test. All patients received OMT for risk factor control.

 

The invasive group received angiography and FFR in all >2.5 mm arteries with 40% – 95% stenosis.  Revascularization was performed when FFR value was ˂0.8.

 

We could conclude that non-invasive initial management of stable chronic angina with cardiovascular MRI was non-inferior to angiography with FFR at one year follow up.

 

Original Title: MR-INFORM: stress perfusion imaging to guide the management of patients with stable coronary artery disease.

Presenter: Nagel EC.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...